Armstrong Fleming & Moore’s Merck MRK Stock Holding History

Armstrong Fleming & Moore’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$985K	Buy	8,188 +250	+3%	+$28.9K	0.42%	40
2025 Q4	$836K	Hold	7,938	–	–	0.39%	40
2025 Q3	$666K	Hold	7,938	–	–	0.32%	50
2025 Q2	$628K	Buy	+7,938	New	+$631K	0.34%	48
2025 Q1	–	Sell	-7,437	Closed	-$740K	–	129
2024 Q4	$740K	Sell	7,437 -525	-7%	-$54.1K	0.45%	39
2024 Q3	$904K	Hold	7,962	–	–	0.53%	36
2024 Q2	$986K	Hold	7,962	–	–	0.63%	30
2024 Q1	$1.05M	Buy	7,962 +1	+0%	+$123	0.73%	27
2023 Q4	$868K	Sell	7,961 -97	-1%	-$10.1K	0.65%	33
2023 Q3	$830K	Sell	8,058 -385	-5%	-$41.5K	0.8%	30
2023 Q2	$974K	Buy	+8,443	New	+$959K	0.9%	29

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armstrong Fleming & Moore's MRK Position: Q1 2026 in Review

Armstrong Fleming & Moore increased its Merck (MRK) stake by 3.1% in Q1 2026, buying an estimated $28.9K and bringing the position to 8,188 shares worth $985K. The position accounts for 0.42% of the portfolio, ranked #40.

Armstrong Fleming & Moore first reported a position in MRK in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.05M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Armstrong Fleming & Moore held 8,188 shares of Merck worth $985K as of Q1 2026.
Armstrong Fleming & Moore bought 250 Merck shares in Q1 2026, an estimated $28.9K.
Merck made up 0.42% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #40 holding.
Armstrong Fleming & Moore first reported a position in Merck in Q2 2023 and has held it in 11 quarters since.
Armstrong Fleming & Moore's Merck position peaked at $1.05M in Q1 2024.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.